Recruiting NA Loxoprofen Sodium Patch

Tests treatment safety and results for Loxoprofen Sodium Patch

Official title The Efficacy and Safety of Loxoprofen Sodium Patch in Relieving Postoperative Pain After Laparoscopic Surgery

ClinicalTrials.gov ID: NCT07591207

What this study is testing

What is Loxoprofen Sodium Patch on the contralateral side?

Loxoprofen Sodium Patch on the contralateral side is an investigational medicine, being studied as a potential treatment for loxoprofen sodium patch.

Also referred to as Active Comparator.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
Studies have shown that up to 80% of patients experience postoperative pain following laparoscopic surgery due to inflammation caused by surgical incisions and surrounding tissues, necessitating pharmacological relief. Inflammatory mediators released from the soft tissues around laparoscopic incisions not only significantly alters the chemical microenvironment at the peripheral terminals of nociceptors, directly inducing pain, but also sensitizes afferent fibers, contributing to peripheral sensitization.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 64

You may be able to join if

  • Patients scheduled for elective Laparoscopic Surgery for laparoscopic cholecystectomy, appendectomy, or hernia repair under general anesthesia;
  • Ages 18 to 64 years old
  • American Society of Anesthesiologists (ASA) physical status of I-III
  • Patients must be able to understand the nature and potential personal consequences of the clinical trial and cooperate with follow-up investigations
  • signing of the informed consent form.

You likely can't join if

  • History of chronic pain syndrome of any cause and mental illness
  • Excessive alcohol or drug abuse, chronic opioid use (more than 2 weeks or 3 days per week for more than 1 month), use of drugs with confirmed or...
  • History of hypertension (Grade 3, extremely high risk)
  • Pregnancy or breastfeeding.
  • Extreme body mass index (BMI) (\ 35).
  • Participation in another treatment trial that interferes with the intervention or outcome of this trial.
See the full eligibility criteria
Who can join
  • Patients scheduled for elective Laparoscopic Surgery for laparoscopic cholecystectomy, appendectomy, or hernia repair under general anesthesia;
  • Ages 18 to 64 years old
  • American Society of Anesthesiologists (ASA) physical status of I-III
  • Patients must be able to understand the nature and potential personal consequences of the clinical trial and cooperate with follow-up investigations
  • signing of the informed consent form.
What rules you out
  • History of chronic pain syndrome of any cause and mental illness
  • Excessive alcohol or drug abuse, chronic opioid use (more than 2 weeks or 3 days per week for more than 1 month), use of drugs with confirmed or suspected sedative or analgesic effects, or use of any painkiller within...
  • History of hypertension (Grade 3, extremely high risk)
  • Pregnancy or breastfeeding.
  • Extreme body mass index (BMI) (\ 35).
  • Participation in another treatment trial that interferes with the intervention or outcome of this trial.
  • Digestive system diseases (such as peptic ulcers, gastric bleeding).
  • Patients with coronary artery disease.
  • Patients with renal impairment (serum creatinine \> 176 µmol/L) and abnormal liver function(alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) \> 2× the upper limit of normal (ULN) or total bilirubin...
  • people with coagulation dysfunction (prothrombin time or activated partial thromboplastin time is higher than the normal threshold) or patients who are taking oral anticoagulants for other medical reasons and have not...
  • Patients with a history of allergy to anyone of the study drugs.

The study team makes the final eligibility decision.

Where it's taking place

  • Beijing, Beijing Municipality, China

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 64 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.